madman
Super Moderator
Adam B. Murphy, MD, discusses the Stockholm3 blood test, which determines prostate cancer risk and may help reduce unnecessary prostate biopsies. Dr. Murphy and colleagues aimed to find out whether this blood test could improve prostate cancer detection in patients from diverse groups in the United States and also reduce unnecessary prostate biopsies in patients with benign or low-grade prostate cancer.
